Synthesis, electrochemistry, and in vitro antileishmanial efficacy of novel ferrocenylazines

Abstract

Leishmaniasis is a zoonotic disease prevalent in 83-92 countries. This disease's current treatments are unsatisfactory because of a variety of shortcomings, including serious toxicity, variable efficacy, painful administration, and the occurrence of parasite resistance to these antileishmanial agents. The